TransMedics Group, Inc.

NASDAQ (USD): TransMedics Group, Inc. (TMDX)

Last Price

159.37

Today's Change

+14.81 (10.24%)

Day's Change

152.19 - 160.80

Trading Volume

1,221,157

Overview

Market Cap

5 Billion

Shares Outstanding

33 Million

Avg Volume

819,347

Avg Price (50 Days)

155.55

Avg Price (200 Days)

116.09

PE Ratio

3988.00

EPS

0.04

Earnings Announcement

04-Nov-2024

Previous Close

144.56

Open

155.22

Day's Range

152.19 - 160.8

Year Range

36.42 - 177.37

Trading Volume

1,222,262

Price Change Highlight

1 Day Change

10.35%

5 Day Change

-3.89%

1 Month Change

-9.42%

3 Month Change

7.92%

6 Month Change

115.22%

Ytd Change

107.71%

1 Year Change

180.30%

3 Year Change

411.12%

5 Year Change

573.36%

10 Year Change

613.42%

Max Change

613.42%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment